ALR | ABT - Moment of Truth Approaching
I wrote about the Alere (NYSE:ALR) - Abbott (NYSE:ABT) merger back in September 2016. Since then there have been a number of developments which have added further complexity to this situation. To summarize, the following are events that occurred since September 2016 (in no particular order):
- Arriva / CMS Debacle
- ALR failure to produce a 10-K
- ALR failed lawsuit against CMS
- ABT arguing for a MAC
- ALR claiming ABT has been improperly withholding information under auspices of "Client Attorney privilege"
- Judge Glasscock threatening that both parties will end up "unhappy" if they choose to litigate
- Super Master Chandler requesting that ABT reveal certain information related to its initial due diligence of ALR
In short, it has been an epic mess and a headache to all involved, including the Delaware Chancery Court.

